MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127 SAR | -0.78% |
|
-5.79% | 0.00% |
| 19/05 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| 06/05 | Avalon Pharma Secures Regulatory Nod for Second Production Facility in Saudi Arabia | MT |
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Companyâs activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
127
SAR
Average target price
107
SAR
Spread / Average Target
-15.75%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 68Cr | |
| +15.91% | 4.2TCr | |
| +22.40% | 2.23TCr | |
| +18.48% | 1.52TCr | |
| +16.12% | 1.4TCr | |
| +45.12% | 1.21TCr | |
| -9.58% | 679.6Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +14.18% | 549.33Cr |
- Stock Market
- Equities
- 4016 Stock
- News Middle East Pharmaceutical Industries Company
- Avalon Pharma Posts Higher FY23 Net Profit, Revenue
